Aethlon Medical INC 10-K annual reports

Aethlon Medical reports progress in its Australian oncology clinical trial while highlighting ongoing going concern risks.

Aethlon Medical, a clinical-stage medical therapeutic company, reported significant operating losses for fiscal year 2025, with auditors raising substantial doubt about its ability to continue as a going concern, despite progress in its Hemopurifier clinical trials and recent capital raises.

Aethlon Medical files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Aethlon Medical's annual report details ongoing efforts in developing the Hemopurifier for cancer and viral infections, while navigating financial challenges and regulatory hurdles.